Episodes
Friday Sep 30, 2022
Friday Sep 30, 2022
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discussing with patients the benefit-risk of a JAK inhibitor.
Version: 20240320
Comments (1)
To leave or reply to comments, please download free Podbean or
The Q&A format works well with 3 contributors.
Friday Oct 07, 2022
To leave or reply to comments,
please download free Podbean App.